deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02127073

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer

Identifying the miR Fingerprint in NAF, Serum, and Tissue in Patients With Ductal Carcinoma in Situ (DCIS) or Invasive Breast Cancer

Sponsor: Montefiore Medical Center

Conditions Breast Cancer Ductal Carcinoma in Situ
Interventions Intranasal Oxytocin
Updated 14 times since 2017 Last updated: Nov 7, 2023 Started: Jan 30, 2015 Primary completion: Jan 18, 2017 Completion: Sep 18, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Could not identify collaborator and secure additional funding after transferring the record to Montefiore Medical Center

Other terminated trials from Montefiore Medical Center

See all terminations from Montefiore Medical Center

Other Breast Cancer trials with similar outcome

Browse all Breast Cancer trials

A PHASE2 clinical study on Breast Cancer and Ductal Carcinoma in Situ, this trial is terminated or withdrawn. The trial is conducted by Montefiore Medical Center and has accumulated 14 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Oct 2019 · 14 months · monthly snapshot~Oct 2019 – ~Jul 2020 · 9 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Sep 2023 · 12 months · monthly snapshot~Sep 2023 – ~Dec 2023 · 3 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Terminated PHASE2

    Status: Suspended → Terminated

  4. Sep 2023 — Dec 2023 [monthly]

    Suspended PHASE2

  5. Sep 2022 — Sep 2023 [monthly]

    Suspended PHASE2

▶ Show 9 earlier versions

  1. Sep 2021 — Sep 2022 [monthly]

    Suspended PHASE2

  2. Jan 2021 — Sep 2021 [monthly]

    Suspended PHASE2

  3. Jul 2020 — Jan 2021 [monthly]

    Suspended PHASE2

  4. Oct 2019 — Jul 2020 [monthly]

    Suspended PHASE2

  5. Aug 2018 — Oct 2019 [monthly]

    Suspended PHASE2

  6. Jul 2018 — Aug 2018 [monthly]

    Suspended PHASE2

    Status: Recruiting → Suspended · Phase: EARLY_PHASE1 → PHASE2

  7. Jun 2018 — Jul 2018 [monthly]

    Recruiting EARLY_PHASE1

  8. Feb 2017 — Jun 2018 [monthly]

    Recruiting EARLY_PHASE1

    Phase: Phase 0 → EARLY_PHASE1

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting Phase 0

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Montefiore Medical Center
Data source: Montefiore Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations